AbC-19TM test to monitor vaccine responses to variants of concern AbC-19TM able to detect antibody response to different vaccines as well as natural infection
Omega Diagnostics Gp (ODX.L) AbC-19 monitors vaccine response to variants
Omega Diagnostics Gp (ODX.L) Final Results
FOR THE YEAR ENDED 31 MARCH 2021
Omega Diagnostics Gp (ODX.L) AbC-19 rapid antibody test performance evaluation
Peer-reviewed performance evaluation and self-test user experience of AbC 19TM
Omega Diagnostics Gp (ODX.L) FDA submission for Emergency Use Authorization
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, announces that following completion of the of US performance studies.
Omega Diagnostics Gp (ODX.L) Statement re. Media Comment
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes the recent media comment that Mologic Ltd have requested for Porton Down to evaluate
Omega Diagnostics Gp (ODX.L) Regulatory progress for VISITECT® COVID-19 test
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, provides the following update on VISITECT® COVID-19 Antigen test regulatory approvals.
Omega Diagnostics Gp (ODX.L) Progress update
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, provides the following update on its UK Government manufacturing contract.
Omega Diagnostics Gp (ODX.L) Positive data for COVID-19 antigen test
Positive study data for Mologic COVID-19 lateral flow antigen test
Omega Diagnostics Gp (ODX.L) Positive data for Mologic COVID-19 antigen test
Further positive data for Mologic COVID-19 lateral flow antigen test
Omega Diagnostics Gp (ODX.L) Launch of VISITECT® COVID-19 Antigen & Update
Rapid diagnostic test for visual detection of SARS-CoV-2 antigen
Omega Diagnostics Gp (ODX.L) CE-Mark: Mologic COVID19 lateral flow antigen test
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, announces that it has CE-Marked Mologic Ltd’s (‘Mologic’) lateral flow antigen test for COVID-19, to
